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It is of great significance to detect disease-associated proteins with high sensitivity, 
selectivity and portability, particularly in clinical practice and diagnostic applications. 
Point-of-care test (POCT) refers to a mean of real-time acquisition of test results by 
portable devices, which are highly desired for detection of biomarkers in daily life. 
The personal glucose meter (PGM) is one of the most widely used devices for patient 
self-testing that the result can be read out by one drop of whole blood. PGM has the 
advantages of easy operation, rapid results acquisition and low sample consumption, 
but its target is restricted to glucose. Liposome is spherical structures composed of a 
bilayer of phospholipids dispersed in water. Liposome can be functional components 
in analytical application due to the encapsulation of a large number of signal 
molecules within the inner cavity. In this work, the enzyme-encapsulated liposome is 
used as the carrier of signal amplification and transduction, and the target signal is 
converted into glucose which can be detected by PGM. By combining these two 
strategies, a universal platform is established for point-of-care testing of 
disease-associated proteins. This method overcomes the shortcoming of PGM for 
glucose only and takes advantages of liposome to achieve the amplification of target 
signal with high detection sensitivity. 
The main work composed of three parts are as follows: 
(1) The amyloglucosidase-encapsulated liposomes are first synthesized and the size 
and morphology of liposomes are characterized. To verify whether the liposomes are 
suitable for analytical system, the dynamics, stability of the liposomes and the 
influence of surfactants on enzyme activity are characterized. 
(2) The method of liposome-based signal amplification system combining with 
dual-aptamer structure is established to detect thrombin. The lipid phosphoramidite 
and lipid modified DNA are synthesized for modification of liposomes. Capture 















liposomes bind with the protein simultaneously to form a “sandwich” structure. 
The breakage of the liposomes leads to the release of a large amount of 
amyloglucosidase encapsulated in the liposomes. The amylose can be catalyzed by 
amyloglucosidase to produce plentiful glucose which can be quantitatively tested by 
the PGM, and the detection limit is 1.8 nM. The method enables fast detection of 
thrombin with high sensitivity and selectivity, and the method has excellent 
versatility. 
(3) The method of liposome-based signal amplification system combining with 
dual-antibody structure is established to detect C-reactive protein (CRP). The capture 
antibody modified magnetic beads (MBs) and biotin DNA labeled liposomes are 
prepared. Capture antibody-conjugated MBs and biotin labeled secondary antibody 
bind with CRP to form a sandwich structure, streptavidin and biotin-labeled 
liposomes are added successively to form further structure. The amylose is 
hydrolyzed by released amyloglucosidase from liposomes to produce glucose which 
can be detected by PGM, and the detection limit of CRP is 0.3 nM. The method 
enables fast detection of CRP with high sensitivity and selectivity, and the method has 
excellent accuracy compared with the traditional ELISA. 
（4）In order to overcome the disadvantages of conventional liposome preparation 
methods, this paper further studies the preparation of liposome by microfluidic 
technique. In this work, micro hydrodynamic focusing technique is used in the 
microfluidic chip to prepare monodisperse populations of liposomes. The liposomes 
with different sizes are prepared by changing the flow parameters, the size of chip 
channels and the design of the chips. The uniform, size controlled liposomes are 
verified by atomic force microscope. 
In summary, this work establishes the liposome-based signal amplification method 
combing with PGM for detection of proteins, and optimizes the preparation method of 
liposomes. The method reported here has the potential for portable and quantitative 
detection of various targets for different POC testing scenarios, such as rapid 
diagnosis in clinic offices, health monitoring at the bedside, and chemical/biochemical 
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